ArticleOpen forum infectious diseases2022

Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.

Amita Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.